Daniel M Bollag - Net Worth and Insider Trading
Daniel M Bollag Net Worth
The estimated net worth of Daniel M Bollag is at least $3 Million dollars as of 2024-04-26. Daniel M Bollag is the Sr. VP, Reg. Affairs & Quality of ARIAD Pharmaceuticals Inc and owns about 129,404 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $3 Million. Daniel M Bollag is also the See Remarks of Ocular Therapeutix Inc and owns about 42,100 shares of Ocular Therapeutix Inc (OCUL) stock worth over $176,399. Details can be seen in Daniel M Bollag's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel M Bollag has not made any transactions after 2018-12-06 and currently still holds the listed stock(s).
Transaction Summary of Daniel M Bollag
Daniel M Bollag Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel M Bollag owns 2 companies in total, including Ocular Therapeutix Inc (OCUL) , and ARIAD Pharmaceuticals Inc (ARIA) .
Click here to see the complete history of Daniel M Bollag’s form 4 insider trades.
Insider Ownership Summary of Daniel M Bollag
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2018-12-06 | SVP,Reg Affairs,Pharma & Qual |
| ARIA | ARIAD Pharmaceuticals Inc | 2017-02-16 | Sr. VP & Reg. Affairs & Quality |
Daniel M Bollag Latest Holdings Summary
Daniel M Bollag currently owns a total of 2 stocks. Among these stocks, Daniel M Bollag owns 129,404 shares of ARIAD Pharmaceuticals Inc (ARIA) as of January 9, 2017, with a value of $3 Million and a weighting of 94.62%. Daniel M Bollag also owns 42,100 shares of Ocular Therapeutix Inc (OCUL) as of December 6, 2018, with a value of $176,399 and a weighting of 5.38%.
Latest Holdings of Daniel M Bollag
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARIA | ARIAD Pharmaceuticals Inc | 2017-01-09 | 129,404 | 23.99 | 3,104,402 |
| OCUL | Ocular Therapeutix Inc | 2018-12-06 | 42,100 | 4.19 | 176,399 |
Holding Weightings of Daniel M Bollag
Daniel M Bollag Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel M Bollag has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 32,000 shares on January 9, 2017, which brought Daniel M Bollag around $760,960.
According to the SEC Form 4 filings, Daniel M Bollag has made a total of 0 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years. The most-recent trade in Ocular Therapeutix Inc is the acquisition of 17,400 shares on December 6, 2018, which cost Daniel M Bollag around $100,224.
Insider Trading History of Daniel M Bollag
- 1
Daniel M Bollag Trading Performance
GuruFocus tracks the stock performance after each of Daniel M Bollag's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel M Bollag is 34.02%. GuruFocus also compares Daniel M Bollag's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel M Bollag within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel M Bollag's insider trading performs compared to the benchmark.
Performance of Daniel M Bollag
Average Return
78.08%
Outperforming Transactions
67%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.67 | 34.02 | 49.86 | 78.08 | 77.01 | 24.2 |
| Relative Return to S&P 500(%) | 1.15 | 28.71 | 41.68 | 70.09 | 65.13 | 9.02 |
Daniel M Bollag Ownership Network
Ownership Network List of Daniel M Bollag
Ownership Network Relation of Daniel M Bollag
Daniel M Bollag Owned Company Details
What does Ocular Therapeutix Inc do?
Who are the key executives at Ocular Therapeutix Inc?
Daniel M Bollag is the SVP,Reg Affairs,Pharma & Qual of Ocular Therapeutix Inc. Other key executives at Ocular Therapeutix Inc include 10 percent owner Summer Road Llc , Chief Business Officer Christopher G White , and Chief Financial Officer Donald Notman .
Ocular Therapeutix Inc (OCUL) Insider Trades Summary
Over the past 18 months, Daniel M Bollag made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 51,149 shares made by Antony C. Mattessich , a net sale of 21,358 shares made by Rabia Gurses Ozden , and a net purchase of 2,476,640 shares made by Summer Road Llc .
In summary, during the past 3 months, insiders sold 88,652 shares of Ocular Therapeutix Inc (OCUL) in total and bought 930,851 shares, with a net purchase of 842,199 shares. During the past 18 months, 134,055 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,483,140 shares were bought by its insiders, resulting in a net purchase of 2,349,085 shares.
Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocular Therapeutix Inc Insider Transactions
Daniel M Bollag Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel M Bollag. You might contact Daniel M Bollag via mailing address: C/o Ariad Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
